TERN

Terns Pharmaceuticals Stock Price

10.51
-0.46 (-4.19%)
Upgrade to Real-Time
Afterhours (Closed)
10.51

Low
6.915

52 Week Range

High
28.36

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Terns Pharmaceuticals Inc TERN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.46 -4.19% 10.51 20:00:00
Open Price Low Price High Price Close Price Prev Close
11.31 10.50 11.98 10.51 10.97
Bid Price Ask Price Spread News
10.53 13.80 3.27 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,703 566,389 $ 11.23 $ 6,358,219 - 6.915 - 28.36
Last Trade Time Type Quantity Stock Price Currency
18:05:29 average 309 $ 10.51 USD

Period:

Draw Mode:

Terns Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 264.12M 25.13M 13.60M $ - $ - -1.29 -5.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 1.10%

more financials information »

Terns Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TERN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.4111.9810.4810.9575,621-0.90-7.89%
1 Month10.0713.7710.0712.0066,4650.444.37%
3 Months13.3713.776.91510.7665,867-2.86-21.39%
6 Months25.5028.366.91517.2994,445-14.99-58.78%
1 Year16.9528.366.91518.51117,828-6.44-37.99%
3 Years16.9528.366.91518.51117,828-6.44-37.99%
5 Years16.9528.366.91518.51117,828-6.44-37.99%

Terns Pharmaceuticals Description

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.


Your Recent History
NASDAQ
TERN
Terns Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.